Ligand validation:2Y0H

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 2Y0H designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Y0H_C8E_A_1400	19%	89%	0.14	0.861	0.49	0.15	-	-	2	0	29%	0.2857
2Y0H_C8E_A_1392	18%	89%	0.162	0.888	0.36	0.27	-	-	0	0	24%	0.2381
2Y0H_C8E_A_1402	18%	80%	0.189	0.861	0.39	0.46	-	-	0	0	52%	0.5238
2Y0H_C8E_A_1393	16%	85%	0.18	0.842	0.32	0.42	-	-	0	0	48%	0.4762
2Y0H_C8E_A_1398	16%	90%	0.18	0.874	0.49	0.14	-	-	0	0	29%	0.2857
2Y0H_C8E_A_1390	15%	81%	0.163	0.85	0.5	0.33	-	-	0	0	29%	0.2857
2Y0H_C8E_A_1395	14%	90%	0.188	0.864	0.3	0.31	-	-	0	0	29%	0.2857
2Y0H_C8E_A_1394	14%	81%	0.212	0.896	0.31	0.51	-	-	0	0	24%	0.2381
2Y0H_C8E_A_1401	13%	72%	0.184	0.868	0.43	0.64	-	-	0	0	19%	19.05
2Y0H_C8E_A_1391	11%	88%	0.174	0.818	0.3	0.36	-	-	0	0	29%	0.2857
2Y0H_C8E_A_1397	9%	87%	0.202	0.808	0.39	0.3	-	-	3	0	33%	0.3333
2Y0H_C8E_A_1396	6%	90%	0.313	0.884	0.32	0.3	-	-	0	0	24%	0.2381
2Y0H_C8E_A_1399	6%	85%	0.224	0.765	0.47	0.27	-	-	0	0	38%	0.381
3T0S_C8E_A_402	20%	89%	0.149	0.889	0.36	0.27	-	-	0	0	24%	0.2381
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1
3RGN_C8E_A_800	76%	74%	0.112	0.947	0.34	0.66	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.